Tech Company Financing Transactions

Hyperion Therapeutics Funding Round

Hyperion Therapeutics closed a $60 million Series C investment round on 7/5/2009. Backers included Bay City Capital, Panorama Capital and Highland Capital Partners.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series C

Bay City Capital (Lead Investor) (Daniel Perez)

Panorama Capital (Lead Investor) (Gaurav Aggarwal)

Highland Capital Partners (Bijan Salehizadeh)

New Enterprise Associates (Jake Nunn)

Sofinnova Ventures (James Healy)

Proceeds Purpose
The capital will fund the Phase III clinical program for UCD as well as a Phase II study in low grade hepatic encephalopathy.

Company Information

Company Status
Acquired or Merged
Mailing Address
601 Gateway Blvd 200
South San Francisco, CA 94080
Email Address
Hyperion Therapeutics, Inc. is a specialty biopharmaceutical company dedicated to improving patients' lives through the development and commercialization of therapies that address critical unmet needs and underserved patient populations. The Company's initial efforts are focused in the areas of gastroenterology and hepatology.
Hyperion Therapeutics LinkedIn Company Profile
Social Media
Hyperion Therapeutics Company Twitter Account
Company News
Hyperion Therapeutics News
Hyperion Therapeutics on Facebook
Hyperion Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Don Santel
  Don Santel LinkedIn Profile  Don Santel Twitter Account  Don Santel News  Don Santel on Facebook
Chief Financial Officer
Jeffrey Farrow
  Jeffrey Farrow LinkedIn Profile  Jeffrey Farrow Twitter Account  Jeffrey Farrow News  Jeffrey Farrow on Facebook
Chief Medical Officer
Bruce Scharschmidt
  Bruce Scharschmidt LinkedIn Profile  Bruce Scharschmidt Twitter Account  Bruce Scharschmidt News  Bruce Scharschmidt on Facebook
Vice President
Christine Nash
  Christine Nash LinkedIn Profile  Christine Nash Twitter Account  Christine Nash News  Christine Nash on Facebook
VP - Bus. Development
Natalie Holles
  Natalie Holles LinkedIn Profile  Natalie Holles Twitter Account  Natalie Holles News  Natalie Holles on Facebook
VP - Regulatory Affairs
Ashley Gould
  Ashley Gould LinkedIn Profile  Ashley Gould Twitter Account  Ashley Gould News  Ashley Gould on Facebook



Browse more venture capital transactions:

Prev: 7/2/2009: StyleCaster venture capital transaction
Next: 7/6/2009: Channelinsight venture capital transaction


Share this article


Where The Data Comes From

We do our best to record funding rounds that are announced publicly. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary